Health Catalyst Net Income
| HCAT Stock | USD 2.32 0.00 0.00% |
As of the 2nd of February, Health Catalyst retains the market risk adjusted performance of (0.34), and Risk Adjusted Performance of (0.11). Health Catalyst technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Health Catalyst Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 0.7383 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -62.6 M | -65.7 M | |
| Net Loss | -123.7 M | -129.8 M | |
| Net Loss | -62.6 M | -65.7 M | |
| Net Loss | (1.04) | (1.09) | |
| Net Income Per E B T | 1.16 | 1.09 |
Health | Net Income | Build AI portfolio with Health Stock |
The evolution of Net Income for Health Catalyst provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Health Catalyst compares to historical norms and industry peers.
Latest Health Catalyst's Net Income Growth Pattern
Below is the plot of the Net Income of Health Catalyst over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Health Catalyst financial statement analysis. It represents the amount of money remaining after all of Health Catalyst operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Health Catalyst's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Health Catalyst's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (69.5 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Health Net Income Regression Statistics
| Arithmetic Mean | (71,757,070) | |
| Coefficient Of Variation | (49.54) | |
| Mean Deviation | 27,852,791 | |
| Median | (60,096,000) | |
| Standard Deviation | 35,544,967 | |
| Sample Variance | 1263.4T | |
| Range | 106.2M | |
| R-Value | (0.55) | |
| Mean Square Error | 941.2T | |
| R-Squared | 0.30 | |
| Significance | 0.02 | |
| Slope | (3,865,580) | |
| Total Sum of Squares | 20215.1T |
Health Net Income History
Other Fundumenentals of Health Catalyst
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Health Catalyst Net Income component correlations
Health Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Health Catalyst is extremely important. It helps to project a fair market value of Health Stock properly, considering its historical fundamentals such as Net Income. Since Health Catalyst's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Health Catalyst's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Health Catalyst's interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Health Care Technology market expansion? Will Health introduce new products? Factors like these will boost the valuation of Health Catalyst. Market participants price Health higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about Health Catalyst listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Health Catalyst is measured differently than its book value, which is the value of Health that is recorded on the company's balance sheet. Investors also form their own opinion of Health Catalyst's value that differs from its market value or its book value, called intrinsic value, which is Health Catalyst's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Health Catalyst's market value can be influenced by many factors that don't directly affect Health Catalyst's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Health Catalyst's value and its price as these two are different measures arrived at by different means. Investors typically determine if Health Catalyst is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Health Catalyst's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Health Catalyst 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Health Catalyst's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Health Catalyst.
| 11/04/2025 |
| 02/02/2026 |
If you would invest 0.00 in Health Catalyst on November 4, 2025 and sell it all today you would earn a total of 0.00 from holding Health Catalyst or generate 0.0% return on investment in Health Catalyst over 90 days. Health Catalyst is related to or competes with Nano X, Prelude Therapeutics, Orchestra BioMed, Caribou Biosciences, Enanta Pharmaceuticals, Outset Medical, and SANUWAVE Health,. Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations More
Health Catalyst Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Health Catalyst's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Health Catalyst upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.17) | |||
| Maximum Drawdown | 21.81 | |||
| Value At Risk | (5.15) | |||
| Potential Upside | 5.42 |
Health Catalyst Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Health Catalyst's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Health Catalyst's standard deviation. In reality, there are many statistical measures that can use Health Catalyst historical prices to predict the future Health Catalyst's volatility.| Risk Adjusted Performance | (0.11) | |||
| Jensen Alpha | (0.72) | |||
| Total Risk Alpha | (0.84) | |||
| Treynor Ratio | (0.35) |
Health Catalyst February 2, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.11) | |||
| Market Risk Adjusted Performance | (0.34) | |||
| Mean Deviation | 2.86 | |||
| Coefficient Of Variation | (612.42) | |||
| Standard Deviation | 3.94 | |||
| Variance | 15.55 | |||
| Information Ratio | (0.17) | |||
| Jensen Alpha | (0.72) | |||
| Total Risk Alpha | (0.84) | |||
| Treynor Ratio | (0.35) | |||
| Maximum Drawdown | 21.81 | |||
| Value At Risk | (5.15) | |||
| Potential Upside | 5.42 | |||
| Skewness | 1.57 | |||
| Kurtosis | 4.61 |
Health Catalyst Backtested Returns
Health Catalyst holds Efficiency (Sharpe) Ratio of -0.12, which attests that the entity had a -0.12 % return per unit of standard deviation over the last 3 months. Health Catalyst exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Health Catalyst's risk adjusted performance of (0.11), and Market Risk Adjusted Performance of (0.34) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 1.87, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Health Catalyst will likely underperform. At this point, Health Catalyst has a negative expected return of -0.48%. Please make sure to check out Health Catalyst's information ratio, as well as the relationship between the potential upside and day median price , to decide if Health Catalyst performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.1 |
Very weak reverse predictability
Health Catalyst has very weak reverse predictability. Overlapping area represents the amount of predictability between Health Catalyst time series from 4th of November 2025 to 19th of December 2025 and 19th of December 2025 to 2nd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Health Catalyst price movement. The serial correlation of -0.1 indicates that less than 10.0% of current Health Catalyst price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.1 | |
| Spearman Rank Test | -0.09 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Health Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Health Catalyst reported net income of (69.5 Million). This is 120.36% lower than that of the Health Care Technology sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 112.17% higher than that of the company.
Health Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Health Catalyst's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Health Catalyst could also be used in its relative valuation, which is a method of valuing Health Catalyst by comparing valuation metrics of similar companies.Health Catalyst is currently under evaluation in net income category among its peers.
Health Catalyst ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Health Catalyst's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Health Catalyst's managers, analysts, and investors.Environmental | Governance | Social |
Health Catalyst Institutional Holders
Institutional Holdings refers to the ownership stake in Health Catalyst that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Health Catalyst's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Health Catalyst's value.| Shares | Kennedy Capital Management Inc | 2025-06-30 | 1.1 M | Connor Clark & Lunn Inv Mgmt Ltd | 2025-06-30 | 1.1 M | Jpmorgan Chase & Co | 2025-06-30 | 909.4 K | Palogic Value Management Lp | 2025-06-30 | 730.1 K | Charles Schwab Investment Management Inc | 2025-06-30 | 598.6 K | Northern Trust Corp | 2025-06-30 | 527 K | Martin & Co Inc | 2025-06-30 | 509.2 K | Schroder Investment Management Group | 2025-06-30 | 468.7 K | Amh Equity Ltd | 2025-06-30 | 427.1 K | First Light Asset Management, Llc | 2025-06-30 | 12.2 M | Blackrock Inc | 2025-06-30 | 5.7 M |
Health Fundamentals
| Return On Equity | -0.31 | ||||
| Return On Asset | -0.0474 | ||||
| Profit Margin | (0.34) % | ||||
| Operating Margin | (0.10) % | ||||
| Current Valuation | 233.36 M | ||||
| Shares Outstanding | 70.73 M | ||||
| Shares Owned By Insiders | 10.10 % | ||||
| Shares Owned By Institutions | 79.76 % | ||||
| Number Of Shares Shorted | 5.07 M | ||||
| Price To Earning | (2.62) X | ||||
| Price To Book | 0.46 X | ||||
| Price To Sales | 0.48 X | ||||
| Revenue | 306.58 M | ||||
| Gross Profit | 150.11 M | ||||
| EBITDA | (10.65 M) | ||||
| Net Income | (69.5 M) | ||||
| Cash And Equivalents | 403.35 M | ||||
| Cash Per Share | 7.37 X | ||||
| Total Debt | 402.26 M | ||||
| Debt To Equity | 0.53 % | ||||
| Current Ratio | 5.15 X | ||||
| Book Value Per Share | 4.70 X | ||||
| Cash Flow From Operations | 14.56 M | ||||
| Short Ratio | 8.99 X | ||||
| Earnings Per Share | (1.57) X | ||||
| Target Price | 3.88 | ||||
| Number Of Employees | 1.5 K | ||||
| Beta | 1.7 | ||||
| Market Capitalization | 152.07 M | ||||
| Total Asset | 858.93 M | ||||
| Retained Earnings | (1.19 B) | ||||
| Working Capital | 139.8 M | ||||
| Current Asset | 216.75 M | ||||
| Current Liabilities | 48.69 M | ||||
| Net Asset | 858.93 M |
About Health Catalyst Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Health Catalyst's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Health Catalyst using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Health Catalyst based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Health Stock Analysis
When running Health Catalyst's price analysis, check to measure Health Catalyst's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Health Catalyst is operating at the current time. Most of Health Catalyst's value examination focuses on studying past and present price action to predict the probability of Health Catalyst's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Health Catalyst's price. Additionally, you may evaluate how the addition of Health Catalyst to your portfolios can decrease your overall portfolio volatility.